SEEFELDT, A. Carolin; FABIAN, Nguyen; ANTUNES, Stephanie; PEREBASKINE, Natacha; GRAF, Michael; ARENZ, Stefan; INAMPUDI, K. Kishore; DOUAT, Celine; GUICHARD, Gilles; WILSON, Daniel N.; INNIS, C. Axel

doi:10.1038/nsmb.3034

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

Langue

Article de revue

Ce document a été publié dans

Nature Structural & Molecular Biology. 2015, vol. 22, n° 6, p. 470-U59

Résumé en anglais

The increasing prevalence of multidrug-resistant pathogenic bacteria is making current antibiotics obsolete. Proline-rich antimicrobial peptides (PrAMPs) display potent activity against Gram-negative bacteria and thus represent an avenue for antibiotic development. PrAMPs from the oncocin family interact with the ribosome to inhibit translation, but their mode of action has remained unclear. Here we have determined a structure of the Onc112 peptide in complex with the Thermus thermophilus 70S ribosome at a resolution of 3.1 angstrom by X-ray crystallography. The Onc112 peptide binds within the ribosomal exit tunnel and extends toward the peptidyl transferase center, where it overlaps with the binding site for an aminoacyl-tRNA. We show biochemically that the binding of Onc112 blocks and destabilizes the initiation complex, thus preventing entry into the elongation phase. Our findings provide a basis for the future development of this class of potent antimicrobial agents.< Réduire

Métadonnées

Partager cette publication !

Licence d’utilisation du document

The proline-rich antimicrobial peptide Onc112 inhibits translation by blocking and destabilizing the initiation complex

Langue

Ce document a été publié dans

Résumé en anglais

URI

DOI

Unités de recherche